PTH 1-84 (parathyroid hormone) clinical trials: 20 trials
Page 1 of 1
Read 20 PTH 1-84 (parathyroid hormone) clinical trials with posted results or linked papers with results in PepBank.
- Sequential Treatment of Postmenopausal Women With Primary Osteoporosis (FP-001-IM)
NCT00365456 · Phase 3 · Completed
Posted results
- Use of NPSP558 in the Treatment of Hypoparathyroidism
NCT00732615 · Phase 3 · Completed
Posted results
- A Study to Learn if Recombinant Human Parathyroid Hormone [rhPTH(1-84)] Can Improve Symptoms and Metabolic Control in Adults With Hypoparathyroidism (BALANCE)
NCT03324880 · Phase 4 · Completed
Posted results
- Effect of Full Length Parathyroid Hormone, PTH(1-84) or Strontium Ranelate on Bone Markers in Postmenopausal Women With Primary Osteoporosis (FP-006-IM)
NCT00479037 · Phase 4 · Completed
Posted results
- The Effect of PTH(1-84) or Alendronate on Reduction of Back Pain in Postmenopausal Women With an Osteoporosis Related Vertebral Fracture(s) (FP-005-IM)
NCT00713258 · Phase 4 · Terminated
Posted results
- Bone Properties in Hypoparathyroidism: Effects of PTH
NCT00473265 · Phase 2/3 · Completed
Posted results
- HEXT (Hypo EXTended): Effect of PTH on Skeleton in Hypoparathyroidism
NCT01199614 · Phase 3 · Completed
Posted results
- A Open-label Study Investigating the Safety and Tolerability of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH [1-84]), for the Treatment of Adults With Hypoparathyroidism - A Clinical Extension Study (RACE)
NCT01297309 · Phase 3 · Completed
Posted results
- PTH & Ibandronate Combination Study (PICS)
NCT00683163 · Phase 2/3 · Completed
Posted results
- Study of Safety and Efficacy of a rhPTH[1-84] of Fixed Doses of 25 and 50 mcg in Adults With Hypoparathyroidism (RELAY)
NCT01268098 · Phase 3 · Completed
Posted results
- A Study of Extended Use of Recombinant Human Parathyroid Hormone (rhPTH(1-84)) in Hypoparathyroidism
NCT02910466 · Phase 4 · Completed
Posted results
- A Study to Investigate the Safety and Tolerability of NPSP558, for the Treatment of Adults With Hypoparathyroidism - A Clinical Extension Study in Hungary
NCT01455181 · Phase 3 · Completed
Posted results
- Safety and Efficacy Study of rhPTH(1-84) in Subjects With Hypoparathyroidism
NCT03364738 · Phase 3 · Terminated
Posted results
- TOP: Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis
NCT00172081 · Phase 3 · Completed
Linked paper with results
- Open Label Extension
NCT00172120 · Phase 3 · Completed
Linked paper with results
- Treatment of Hypoparathyroidism With Subcutaneous PTH (1-84) Injections: Effects on Muscle Function and Quality of Life
NCT00730210 · Phase 2 · Completed
Linked paper with results
- A Study of Relative Bioavailability of a New Formulation Compared With the Approved Formulation of rhPTH [1-84] and to Find Out Dose Linearity of the New Formulation in Healthy Adults
NCT05137730 · Phase 1 · Completed
Posted results
- Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) When Given Once and Twice Daily to Participants With Hypoparathyroidism
NCT02781844 · Phase 1 · Completed
Posted results
- Study of rhPTH(1-84) in Japanese Healthy Subjects Compared With Matched Caucasian Healthy Adult Subjects
NCT03150108 · Phase 1 · Completed
Posted results
- Adherence to PTH(1-84) Treatment (FP-002-IM)
NCT00478569 · Phase not stated · Completed
Posted results